Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.19 0.0700 +58.33%
ARIA $9.89 2.9100 +41.69%
EPZM $20.10 2.6000 +14.86%
SNSS $1.21 0.1500 +14.15%
BLRX $1.53 0.1700 +12.50%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CCXI $6.50 -0.3900 -5.66%
NWBO $8.11 -0.1900 -2.29%
PGNX $7.67 -0.1600 -2.04%
VBLT $5.31 -0.1100 -2.03%
PFE $32.66 -0.6000 -1.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

How to Know Whether to Believe a Health Study

(New York Times/The Upshot) Aug 17, 2015 - One of the chief limitations of randomized trials is that they’re typically focused on narrow populations that meet strict criteria — those most likely to benefit from treatment.
read article 

Teens' e-Cigarette Use Linked With Later Smoking

(ABC News/Associated Press) Aug 18, 2015 - Teens who use e-cigarettes are more likely than others to later smoke conventional cigarettes and other tobacco products, a study at 10 Los Angeles high schools suggests.
read article 

Dr. Iuliana Shapira Named Chief of Hematology and Oncology at SUNY Downstate

(SUNY Downstate Medical Center) Aug 17, 2015 - Iuliana Shapira, MD, has joined SUNY Downstate Medical Center as chief of the Division of Hematology and Oncology, it was announced by Moro Salifu, MD, MBA, MPH, FACP, professor and chair of the Department of Medicine.
read press release 

WHO Appoints Canadian Oncologist To Help Guide Women's Cancer Care In Developing Nations

(Metro News Canada/The Canadian Press) Aug 17, 2015 - A Canadian oncologist has been appointed by the World Health Organization to help create guidelines and programs to provide earlier diagnosis and treatment of cancers that are killing more women in developing countries each year.
read article 

American Society of Hematology Awards Bridge Grants to Help Sustain Blood Disease Research

(ASH) Aug 18, 2015 - The American Society of Hematology, the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the 13 investigators who will receive ASH Bridge Grants for promising blood disease research that could otherwise not be funded by the National Institutes of Health as a result of severe federal funding restrictions.
read press release 

Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizations In Measuring Effectiveness Of Programs

(MarketWatch) Aug 18, 2015 - Amgen and the Center for Social Sector Leadership at the University of California (UC), Berkeley's Haas School of Business today announced a multi-year partnership to offer a graduate-level course on measuring outcomes of cancer patient advocacy education and support programs.
read article 

Opinion: Quigley: Push Drugmakers To Lower Price Of Cancer Medicine

(Indianapolis Star) Aug 18, 2015 - No one understands the value of medicines better than famed Indiana University School of Medicine professor and oncologist Dr. Lawrence Einhorn.
read article 

Arno Therapeutics Receives Authorization to Proceed With Modified Phase I/II Trial Evaluating Onapristone in Prostate Cancer

(TheStreet) Aug 18, 2015 - Arno Therapeutics, Inc. today announced that it has received authorization from the Medicines and Healthcare products Regulatory Authority (MHRA) to begin enrolling patients in the United Kingdom in the second stage of its Phase I/II clinical trial evaluating lead compound onapristone in men with advanced castration-resistant prostate cancer (CRPC).
read article 

N-of-One Selected by Spectrum Health to Provide Clinical Interpretation for 50-Gene Hot-Spot Solid Tumor Panel

(Yahoo! Finance) Aug 18, 2015 - N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed an agreement with Spectrum Health to provide clinical interpretation for all cases sequenced on Spectrum Health’s 50-gene hot-spot solid tumor panel.
read article 

The Wistar Institute and BioTime Subsidiary OncoCyte Corporation Expand Agreement to Develop Molecular Diagnostic Test for the Detection of Lung Cancer

(Yahoo! Finance) Aug 18, 2015 - Agreement provides for continued development of a liquid biopsy test designed to aid physicians in the early, non-invasive detection of lung cancer.
read article 

Insys Therapeutics' Dronabinol Oral Solution NDA Accepted for Filing by FDA

(MarketWatch) Aug 17, 2015 - Insys Therapeutics, Inc. today announced that the New Drug Application (NDA) for its proprietary Dronabinol Oral Solution has been accepted for filing by the U.S. Food and Drug Administration ("FDA").
read article 

Opportunity For Roche To Further Strengthen Its Cancer Business Against Evolving Competition

(Forbes) Aug 18, 2015 - Roche Holdings may be expediting the approval of Atezolizumab, which is still some time away.
read article 

MRI Scans Can Deliver Cancer Therapy

(BBC News) Aug 18, 2015 - A hospital scan normally used to detect cancer could be used to steer tumour killing treatments to hard-to-reach targets in the body, say scientists. The UK team at Sheffield University deployed the magnetic power of MRI scans to control the movement of a specially designed injectable cancer therapy.
read article 

Aspirin Lowers Bowel Cancer Risk In Obese People With Inherited Cancer Syndrome

(Cancer Research UK/Press Association) Aug 17, 2015 - Aspirin can more than halve bowel cancer risk in obese people with Lynch syndrome - an inherited condition linked to an increased risk of cancer - according to data from a UK clinical trial.
read article 

Genetic Test Could Improve Blood Cancer Treatment

(ICR [UK]) Aug 17, 2015 - New research, published in the Journal of Clinical Oncology today, found as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive treatment.
read article 

Side Effects May Lead Breast Cancer Patients To Skip Drugs

( Aug 18, 2015 - Breast cancer patients who report more side effects of their hormone therapy drugs and less confidence communicating with their doctors are more likely to intentionally or unintentionally miss a dose, according to a new study.
read article 

Study: High Stroma Levels Linked To Pancreatic Cancer

(The Arizona Republic) Aug 18, 2015 - Ask the Expert: A TGen study of pancreatic cancer patients has given scientists a better understanding of how to treat cancerous tumors.
read article 

Antigen Level Signals Response to Chemo for Pancreatic Cancer

(Doctors Lounge/HealthDay News) Aug 17, 2015 - A drop in carbohydrate antigen (CA) 19-9 levels of more than 10 percent after two rounds of chemotherapy is associated with longer survival in patients with advanced pancreatic ductal adenocarcinoma (PDAC), according to a study published online Aug. 6 in the Journal of Gastroenterology and Hepatology.
read article 

A Fuller Life After Rectal Cancer Treatment

(Wall Street Journal) Aug 17, 2015 - Doctors say there’s less reason than ever for certain cancer patients to fear the colostomy bag. Medical advances are making it easier for the 40,000 Americans diagnosed with rectal cancer each year to resume normal lives after treatment.
read article (paid subscription required) 

Daily Coffee May Boost Colon Cancer Survival

(New York Times/Well blog) Aug 17, 2015 - Colon cancer patients who were heavy coffee drinkers had a far lower risk of dying or having their cancer return than those who did not drink coffee, with significant benefits starting at two to three cups a day, a new study found.
read article 

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

(StreetInsider) Aug 18, 2015 - Merck, known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy.
read article 

Seattle Genetics Announces FDA Regular Approval of ADCETRIS® (Brentuximab Vedotin) for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression as Post-Autologous Hematopoietic Stem Cell Transplantation Consolidation

(MarketWatch) Aug 17, 2015 - Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS (brentuximab vedotin) for the treatment of patients with classical Hodgkin lymphoma (HL) at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation.
read article 

AVEO Announces Exclusive Worldwide License Agreement for the Development and Commercialization of AV-380 and Related Antibodies

(StreetInsider) Aug 17, 2015 - AVEO Oncology today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEO's first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies, including modified or derivative forms of any such antibody.
read article 

Kite Pharma Provides Update on KTE-C19 Clinical Trial

(Kite) Aug 17, 2015 - Kite Pharma, Inc. today provided an update from the Company's ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin's lymphoma (NHL) who have failed prior chemotherapy treatments and have a poor prognosis.
read corporate press release 

Opinion: A Free-Speech Clinic for the FDA

(Wall Street Journal) Aug 14, 2015 - The Food and Drug Administration thinks its powers are so total that it can even prohibit drug companies from making true claims about their products. Not so fast. A federal judge in an important and closely watched test case in New York has called this political control a violation of the First Amendment.
read article (paid subscription required)